BLRX
BioLineRX
BLRX
BLRX
15 hedge funds and large institutions have $8.01M invested in BioLineRX in 2013 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.
Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.44%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
O
1
OrbiMed
New York
|
$3.19M |
| 2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$405K |
| 3 |
3
Renaissance Technologies
New York
|
$29K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
O
1
OrbiMed
New York
| $3.19M | 1,135,000 | -200,000 | -15% |
|
|
OM
2
Opaleye Management
Boston,
Massachusetts
| $2.07M | 713,000 | +713,000 | New |
|
|
SM
3
Senvest Management
New York
| $2.05M | 730,310 | +39,156 | +6% |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $405K | 144,250 | -60,330 | -29% |
|
5
UBS AM
Chicago,
Illinois
| $85K | 30,000 | +30,000 | New |
|
6
Bank of New York Mellon
New York
| $50K | 17,800 | – | – |
|
|
VKH
7
Virtu KCG Holdings
New York
| $37K | 13,129 | +2,428 | +23% |
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $34K | 12,000 | – | – |
|
|
9
Renaissance Technologies
New York
| $29K | 10,200 | -51,400 | -83% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $28K | 10,008 | +8,285 | +481% |
|
|
ARTA
11
A.R.T. Advisors
New York
| $28K | 10,042 | +10,042 | New |
|
12
Wells Fargo
San Francisco,
California
| $3K | 1,000 | – | – |
|
13
Citigroup
New York
| $0 | 47 | -436 | -90% |
|
14
Ameriprise
Minneapolis,
Minnesota
| $0 | 10 | – | – |
|
15
Creative Planning
Overland Park,
Kansas
| $0 | 140 | – | – |
|